|
US5266552A
(en)
|
1991-11-12 |
1993-11-30 |
Imperial Chemical Industries Plc |
Arylphosphonoamidate herbicides
|
|
US5958905A
(en)
|
1996-03-26 |
1999-09-28 |
Texas Biotechnology Corporation |
Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin
|
|
US5807846A
(en)
|
1996-11-14 |
1998-09-15 |
Warner-Lambert Company |
Phosphonamide ACAT inhibitors
|
|
SK12442001A3
(sk)
|
1999-03-05 |
2002-06-04 |
Metabasis Therapeutics, Inc. |
Cyklické fosforamidáty, spôsob ich prípravy a farmaceutické kompozície, ktoré ich obsahujú
|
|
US7132427B2
(en)
|
2001-06-21 |
2006-11-07 |
Ariad Pharmaceuticals, Inc. |
Quinazolines and uses thereof
|
|
WO2004058267A1
(en)
|
2002-12-23 |
2004-07-15 |
Ariad Pharmaceuticals, Inc. |
Heterocycles and uses thereof
|
|
CN101171241A
(zh)
*
|
2005-03-11 |
2008-04-30 |
密执安州立大学董事会 |
抗细胞凋亡的bcl-2家族成员的色烯-4-酮抑制剂及其应用
|
|
US7834023B2
(en)
*
|
2006-09-20 |
2010-11-16 |
Portola Pharmaceuticals, Inc. |
Substituted dihydroquinazolines as platelet ADP receptor inhibitors
|
|
US20080249130A1
(en)
*
|
2007-02-09 |
2008-10-09 |
Sirtris Pharmaceuticals, Inc. |
Gut microsomal triglyceride transport protein inhibitors
|
|
WO2009009041A2
(en)
*
|
2007-07-06 |
2009-01-15 |
Kinex Pharmaceuticals, Llc |
Compositions and methods for modulating a kinase cascade
|
|
US8563735B2
(en)
|
2008-12-05 |
2013-10-22 |
Abbvie Inc. |
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
|
|
TWI535712B
(zh)
|
2010-08-06 |
2016-06-01 |
阿斯特捷利康公司 |
化合物
|
|
CA2822039C
(en)
|
2010-12-16 |
2019-05-28 |
Allergan, Inc. |
Sulfur derivatives as chemokine receptor modulators
|
|
KR101762724B1
(ko)
*
|
2011-01-25 |
2017-07-28 |
더 리젠츠 오브 더 유니버시티 오브 미시건 |
Bcl-2/bcl-xl 억제제 및 이를 이용한 치료 방법
|
|
US20140189897A1
(en)
|
2011-06-21 |
2014-07-03 |
Mayo Foundation For Medical Education And Research |
Transgenic animals capable of being induced to delete senescent cells
|
|
WO2013052943A2
(en)
*
|
2011-10-06 |
2013-04-11 |
The Regents Of The University Of Michgian |
Small molecule inhibitors of mcl-1 and uses thereof
|
|
US9901080B2
(en)
|
2012-08-23 |
2018-02-27 |
Buck Institute For Research On Aging |
Transgenic mouse having a transgene that converts a prodrug into a cytotoxic compound in senescent cells
|
|
EP2922544B1
(en)
|
2012-11-21 |
2018-08-01 |
Eutropics Pharmaceuticals, Inc. |
Methods and compositions useful for treating diseases involving bcl-2 family proteins with quinoline derivatives
|
|
EP2945940B1
(en)
|
2013-01-16 |
2020-07-15 |
The Regents of The University of Michigan |
Bcl-2/bcl-xl inhibitors and their use in the treatment of cancer
|
|
BR112015026702A2
(pt)
|
2013-04-21 |
2018-02-06 |
Yeda Res And Developmente Co Ltd |
métodos de extermínio de células senescentes
|
|
US20170216286A1
(en)
|
2014-01-28 |
2017-08-03 |
Mayo Foundation For Medical Education And Research |
Killing senescent cells and treating senescence-associated conditions using a src inhibitor and a flavonoid
|
|
US10328058B2
(en)
*
|
2014-01-28 |
2019-06-25 |
Mayo Foundation For Medical Education And Research |
Treating atherosclerosis by removing senescent foam cell macrophages from atherosclerotic plaques
|
|
US9993472B2
(en)
|
2014-01-28 |
2018-06-12 |
Unity Biotechnology, Inc. |
Treatment for osteoarthritis in a joint by administering a means for inhibiting MDM2
|
|
WO2015113944A1
(en)
|
2014-01-28 |
2015-08-06 |
Universiteit Gent |
Pyrabactin analogues to modulate plant development
|
|
EP3125943B1
(en)
|
2014-04-04 |
2026-04-22 |
Merck Sharp & Dohme LLC |
Phosphate based linkers for intracellular delivery of drug conjugates
|
|
CN106456699B
(zh)
|
2014-05-05 |
2021-07-02 |
生物风险投资有限责任公司 |
作为抗老化剂抑制抗凋亡的Bcl-2蛋白的组合物和方法
|
|
CZ2014915A3
(cs)
|
2014-12-16 |
2016-02-24 |
Univerzita Karlova v Praze, Farmaceutická fakulta v Hradci Králové |
Substituovaný derivát kyslíkatých kyselin fosforu, jeho použití a farmaceutický přípravek ho obsahující
|
|
JP2018508569A
(ja)
|
2015-02-06 |
2018-03-29 |
ユニティ バイオテクノロジー インコーポレイテッド |
老化関連状態の治療における化合物および使用
|
|
US20180000816A1
(en)
*
|
2015-02-06 |
2018-01-04 |
Unity Biotechnology, Inc. |
Use of a Heterocyclic Bcl-xL Inhibitor and Related Analogs for Removing Senescent Cells in the Treatment of Eye Diseases and Other Age-Related Conditions
|
|
US10195213B2
(en)
|
2015-03-13 |
2019-02-05 |
Unity Biotechnology, Inc. |
Chemical entities that kill senescent cells for use in treating age-related disease
|
|
CN107846899A
(zh)
|
2015-07-15 |
2018-03-27 |
拜耳农作物科学股份公司 |
取代的氧代四氢喹啉基次膦酰胺和‑膦酰胺或其盐及其提高植物中的胁迫耐受性的用途
|
|
CN105646587B
(zh)
*
|
2016-03-02 |
2018-03-23 |
云南中医学院 |
1,3,2‑氧氮磷杂环戊烷类化合物、制备方法及应用
|
|
WO2019001171A1
(zh)
|
2017-06-27 |
2019-01-03 |
维眸生物科技上海有限公司 |
一种含磷化合物及其制备和应用
|
|
WO2019028391A1
(en)
|
2017-08-03 |
2019-02-07 |
The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Vegas |
DIALKYL PHOSPHONATE DIRECT METAL-FREE ARYLATION FOR THE SYNTHESIS OF MIXED ALKYL ARYLATED PHOSPHONATES
|
|
WO2019033122A1
(en)
|
2017-08-11 |
2019-02-14 |
Unity Biotechnology, Inc. |
TREATMENT OF PULMONARY DISEASES USING PHARMACEUTICAL AGENTS THAT ELIMINATE SENESCENT CELLS
|
|
CN111372598A
(zh)
|
2017-08-11 |
2020-07-03 |
联合生物科技公司 |
使用消除衰老细胞的药剂治疗诸如黄斑变性,青光眼,和糖尿病性视网膜病变等眼科状况
|